AbClon Inc - ESG Rating & Company Profile powered by AI
The page displays a free E,S&G report covering AbClon Inc. Alternative companies in the rating industry group for AbClon Inc are shownin the table. This report of AbClon Inc is prepared by All Street Sevva using cutting edge artificial intelligence.
AbClon Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | AbClon Inc | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does AbClon Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes AbClon Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes AbClon Inc report the average age of the workforce?
Sign up for free to unlockDoes AbClon Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes AbClon Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes AbClon Inc disclose cybersecurity risks?
Sign up for free to unlockDoes AbClon Inc offer flexible work?
Sign up for free to unlockDoes AbClon Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes AbClon Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes AbClon Inc conduct supply chain audits?
Sign up for free to unlockDoes AbClon Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes AbClon Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes AbClon Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes AbClon Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes AbClon Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes AbClon Inc disclose water use targets?
Sign up for free to unlockDoes AbClon Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid AbClon Inc have a product recall in the last two years?
Sign up for free to unlockDoes AbClon Inc disclose incidents of discrimination?
Sign up for free to unlockDoes AbClon Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas AbClon Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes AbClon Inc disclose parental leave metrics?
Sign up for free to unlockDoes AbClon Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes AbClon Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes AbClon Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes AbClon Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes AbClon Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes AbClon Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs AbClon Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes AbClon Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes AbClon Inc disclose its waste policy?
Sign up for free to unlockDoes AbClon Inc report according to TCFD requirements?
Sign up for free to unlockDoes AbClon Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes AbClon Inc disclose energy use targets?
Sign up for free to unlockDoes AbClon Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes AbClon Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for AbClon Inc
These potential risks are based on the size, segment and geographies of the company.
AbClon Inc. engages in the research and development of antibody drugs in South Korea and Sweden. It offers Atlas antibodies; essential antibodies for bio-researchers; and Absignal, a western detection agent. The company's products in pipeline include NEST platform technology products for stomach, breast, colorectal, lung, and solid cancers; AffiMab platform technology products for pancreatic, colorectal, and lung cancers, as well as for rheumatoid arthritis and psoriasis; and CAR-T platform technology products for hematologic cancers. It also develops BioSynergy antibody drugs that act as a mechanism for the existing disease protein based on YPLUS and AffiMab. In addition, the company offers peptide and protein for antibody development; monoclonal antibody service for various antigens comprising peptide, protein, and recombinant proteins; polyclonal antibody for use in research; ELISA, a method for drug development, diagnostic kit, HCP kit, and protein kit at various industry and academia; and antibody drug development services. It sells its products through distributors in Japan, China and Hong Kong, Taiwan, Singapore, and Malaysia. AbClon Inc. was founded in 2010 and is based in Seoul, South Korea.